01-01-2016 | Healthcare Policy and Outcomes
Global Cancer Surgery, or Lack Thereof: A Wake-Up Call
Published in: Annals of Surgical Oncology | Issue 1/2016
Login to get accessExcerpt
The alarming predictions of the rising global cancer burden should not come as any surprise to the informed reader and must serve as a prompt and substantial wake-up call for anyone involved in the delivery of cancer care.1 A glimpse of the worrisome metrics associated with the rising global cancer burden is outlined in Table 1. The magnitude of the pervasive consequences of rising global cancer burden on the individual patient, as well as the nation and the entire world, are increasingly evident. Several attempts and initiatives are under way to address this rising global cancer burden by targeting various points in the global chain of cancer care delivery. To address any issue, one needs to be aware of the magnitude of the problem and the myriad deficiencies associated with its targeted amelioration. The Lancet Oncology Commission on Global Cancer Surgery is a laudable attempt to address the inequities in cancer care with particular emphasis on the gross lack of surgical care for patients afflicted with cancer.1
2015
|
15.2 million new cancer patients, of whom 80 % will need surgery and 8.8 million of whom will experience cancer-related deaths
|
2030
|
45 million surgical procedures will be needed to treat cancer patients
|
2012
|
57 % of all new cancer cases and 65 % of all cancer-related deaths occur in LMICs
|
5 %
|
Percentage of global spending on cancer that occurs in the LMICs, although they account for the majority for the cases
|
2030
|
21.6 million new cancer cases, of which 17.3 million will need surgery
|
227
|
Number of different surgical procedures needed to treat cancers across all complexity
|
<5 %
|
Percentage of people from LMICs that have access to safe, affordable, and timely cancer surgery
|
25–31 %
|
Percentage of patients who will face catastrophic expenditure or bankruptcy after cancer surgery
|
$2 trillion
|
Lost worldwide gross domestic product (between 2015 and 2013) due to economic burden of surgical cancers
|
$100 billion
|
Global spending on cancer drugs in 2014
|
14 %
|
Percentage of patients who have access to and receive palliative care
|
82 %
|
Percentage of countries that cannot have access to adequate number of cancer surgeons, with most in the low- to middle-income categories
|
93 %
|
Global cancer research undertaken by 35 countries worldwide, with only 8 LMICs contributing just 15.2 % of the worldwide output of research
|